Strategic Partnership Recent collaboration with PepGel LLC signals openness to co-develop and integrate next-generation 3D cell culture and related life science solutions, presenting a ripe channel for joint offerings, bundled devices, and expanded distribution to US and Canadian markets.

Targeted Market Gap Low revenue scale yet broad product portfolio across 2D/3D imaging, EV isolation, and membrane binding analysis suggests a need for tiered solutions and value-based propositions that can scale from early-stage labs to institutional buyers in biotech and pharma.

Key Customer Segments Focus areas include drug discovery labs, academic research centers, and in-vitro/vivo assay developers who require advanced imaging, SPR-based kinetics analysis, and diagnostic kits, offering upsell opportunities for integrated instrument suites and consumables.

Digital & Branding Existing tech stack and online presence (WordPress, Microsoft 365, Google Fonts, etc.) provide a lean platform for marketing automation, lead capture, and content-driven campaigns to attract rebuilt awareness in niche life science channels.

Competitive Positioning With peers in biopharma supply and life science research tools, emphasize agility, customization, and localized US/Canada service as differentiators, while targeting mid-market accounts that may be underserved by larger incumbents.